Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease (Q33996145)

30 July 2017

1 reference

title

Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease (English)

1 reference

30 July 2017

0 references

McGeer PL

1

1 reference

30 July 2017

1 July 2000

1 reference

30 July 2017

1 reference

30 July 2017

17

1 reference

30 July 2017

1

1 reference

30 July 2017

1-11

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200017010-00001

30 July 2017

0 references

cites work

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

1 reference

12 December 2020

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II.

1 reference

12 December 2020

Cyclooxygenases and the central nervous system

1 reference

12 December 2020

Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles

1 reference

12 December 2020

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

12 December 2020

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation

1 reference

12 December 2020

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

1 reference

12 December 2020

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

12 December 2020

Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia

1 reference

12 December 2020

Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain.

1 reference

12 December 2020

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

12 December 2020

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

12 December 2020

Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death.

1 reference

12 December 2020

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

12 December 2020

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

1 reference

12 December 2020

Increased levels of cyclooxygenase-2 mRNA in the rat spinal cord after peripheral inflammation: an in situ hybridization study

1 reference

12 December 2020

Effect of selective inhibition of cyclooxygenase 2 on temporary focal cerebral ischemia in rats

1 reference

12 December 2020

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

12 December 2020

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

12 December 2020

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

12 December 2020

Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage.

1 reference

12 December 2020

Rheumatoid arthritis and susceptibility to Alzheimer's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Prostaglandin H synthase-2 and cytosolic phospholipase A2 in the hypoxic-ischemic brain: role in neuronal death or survival?

1 reference

12 December 2020

Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus

1 reference

12 December 2020

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

12 December 2020

An E-box region within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells

1 reference

12 December 2020

Induction of cyclooxygenase-2 in the rat brain after a mild episode of focal ischemia without tissue inflammation or neural cell damage

1 reference

12 December 2020

Inhibition of prostanoid synthesis protects against neuronal damage induced by focal ischemia in rat brain

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.

1 reference

12 December 2020

Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage

1 reference

12 December 2020

Outcome of specific COX-2 inhibition in rheumatoid arthritis.

1 reference

12 December 2020

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

1 reference

12 December 2020

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

12 December 2020

New insights into the mode of action of anti-inflammatory drugs.

1 reference

12 December 2020

Anti-inflammatory drugs and Alzheimer-type pathology in aging.

1 reference

12 December 2020

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

12 December 2020

COX-1 and COX-2 tissue expression: implications and predictions

1 reference

12 December 2020

Increased affinity of type II corticosteroid binding in aged rat hippocampus

1 reference

12 December 2020

Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever

1 reference

12 December 2020

Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

1 reference

12 December 2020

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

12 December 2020

Pain management in osteoarthritis: the role of COX-2 inhibitors

1 reference

12 December 2020

Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element

1 reference

12 December 2020

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

12 December 2020

Effects of indomethacin on cerebral blood flow and oxygen metabolism: a positron emission tomographic investigation in the anaesthetized baboon.

1 reference

12 December 2020

Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings

1 reference

12 December 2020

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

1 reference

12 December 2020

10.2165/00002512-200017010-00001

Identifiers

DOI

1 reference

PubMed ID

10933512

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

10933512